Cepheid Tuberculosis Drug Resistance Test Receives WHO Prequalification

{
  "signal_id": "820d8b6d-0ea9-4066-97f9-4ff52cf52938",
  "signal_type": "news",
  "signal_subtype": "signs_new_client",
  "detected_at": "2025-10-28T13:52:48+00:00",
  "company": {
    "name": "Danaher",
    "domain": "danaher.com"
  },
  "data": {
    "url": "https://www.genomeweb.com/molecular-diagnostics/cepheid-tuberculosis-drug-resistance-test-receives-who-prequalification",
    "title": "Cepheid Tuberculosis Drug Resistance Test Receives WHO Prequalification",
    "excerpt": "Cepheid tuberculosis drug resistance test receives WHO prequalification.\n\nNEW YORK - Danaher subsidiary Cepheid announced Tuesday that its Xpert MTB/XDR test for tuberculosis drug resistance has been awarded prequalification status by the World Health Organization.\n\nTo read the full story...",
    "summary": "Danaher signed new client World Health Organization International on Oct 28th '25.",
    "category": "signs_new_client",
    "found_at": "2025-10-28T13:52:48Z",
    "location": "New York, New York, United States",
    "planning": false,
    "image_url": "https://crain-platform-genomeweb-prod.s3.amazonaws.com/s3fs-public/logo.svg",
    "confidence": 0.4434,
    "published_at": "2025-10-28T13:53:34Z",
    "location_data": [
      {
        "city": "New York",
        "state": "New York",
        "country": "United States",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2025-10-28",
    "article_sentence": "NEW YORK - Danaher subsidiary Cepheid announced Tuesday that its Xpert MTB/XDR test for tuberculosis drug resistance has been awarded prequalification status by the World Health Organization."
  }
}

curl https://signals.autobound.ai/v1/signals/820d8b6d-0ea9-4066-97f9-4ff52cf52938 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"danaher.com","limit":20}'